Imugene Ltd has released a press release.
First Patient in BTKi Combination Cohort of azer-cel study
Earlier from Imugene
- Azer-cel Data from CAR T naive cohort in ASCO 2026 abstract
- Diamond Equity Research Releases Update Note on Imugene Limited (ASX: IMU)
- Prospectus
- $20M placement and SPP, convertible notes amended